相互作用
Artesunate + Eltrombopag
重症度: 中等度
Artesunate and Eltrombopag: moderate interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Artesunate is converted to dihydroartemisinin (DHA), which is cleared by glucuronidation through UGT1A9 and UGT2B7. Eltrombopag inhibits UGT enzymes in vitro, so DHA exposure could rise, with possible increased adverse effects.
この相互作用をわかりやすく説明すると
Artesunate and Eltrombopag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Artesunate belongs to Anti Parasitic; Eltrombopag belongs to Miscellaneous.
なぜ起こるのか
Eltrombopag inhibits UGT enzymes in vitro and may reduce glucuronidation of the active metabolite DHA.
対処法
Monitor for artesunate adverse effects such as hemolysis and hepatic changes, and monitor platelet counts and liver tests. No empirical dose change is recommended.
薬剤師に尋ねること
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、ArtesunateとEltrombopagの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を7日間無料でお試し。カード登録不要。
Eltrombopagのその他の相互作用
Artesunateのその他の相互作用
よくある質問
Can I take Artesunate with Eltrombopag?
MediHelp rates the interaction as moderate. Artesunate and Eltrombopag can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Artesunate is converted to dihydroartemisinin (DHA), which is cleared by glucuronidation through UGT1A9 and UGT2B7. Eltrombopag inhibits UGT enzymes in vitro, so DHA exposure could rise, with possible increased adverse effects.
How serious is the interaction between Artesunate and Eltrombopag?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for artesunate adverse effects such as hemolysis and hepatic changes, and monitor platelet counts and liver tests. No empirical dose change is recommended.
What other medicines interact with Eltrombopag?
MediHelp also lists interactions of Eltrombopag with, for example, Alpelisib, Aluminum hydroxide, Amobarbital. The full list is on the Eltrombopag page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
